Radosław Januchowski

11PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 15, 2026
Vismodegib Exerts a Pleotropic Effect on Topotecan-Resistant and Sensitive Ovarian Cancer Cell Lines in 2D and 3D Cell Culture Models.

|Apr 28, 2023
Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer.

Wojciech A Cieślikowski, Piotr Milecki, Monika Świerczewska

|Mar 25, 2022
Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model.

Marta Nowacka, Barbara Ginter-Matuszewska, Monika Świerczewska

|Apr 30, 2021
Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs.

Karolina Wojtowicz, Karolina Sterzyńska, Monika Świerczewska

|Jan 16, 2020
Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer.

Wojciech A Cieślikowski, Joanna Budna-Tukan, Monika Świerczewska

|Aug 16, 2019
Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines.

Karolina Sterzyńska, Dominika Kaźmierczak, Andrzej Klejewski

Pageof 2

Frequent Collaborators

7 joint publications

Radosław Januchowski

6 joint publications

Karolina Sterzyńska

3 joint publications

Michał Nowicki

2 joint publications

Joanna Budna-Tukan